| Literature DB >> 33203254 |
Takahiro Makino1, Shota Takenaka1, Yusuke Sakai1, Hideki Yoshikawa1, Takashi Kaito1.
Abstract
STUDYEntities:
Keywords: cage; quality of life; subsidence; three-dimensional porous titanium; titanium-coated poly-ether-ether-ketone; vertebral endplate cyst
Year: 2020 PMID: 33203254 PMCID: PMC9344530 DOI: 10.1177/2192568220972334
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Demographic and Operative Data.
| TCP | PTA | P value | |
|---|---|---|---|
| Age (years) | 71 (64–76) | 69 (64–76) | 0.609 |
| Gender (male: female) | 11:23 | 14:15 | 0.301 |
| Pathology | >0.999 | ||
| Disc herniation | 3 | 2 | |
| Spinal canal stenosis with foraminal stenosis | 3 | 3 | |
| Degenerative spondylolisthesis | 26 | 22 | |
| Isthmic spondylolisthesis | 2 | 2 | |
| BMI (kg/m2) | 23.2 (21.3–25.4) | 24.2 (21.1–26.3) | 0.730 |
| DM (y: n) | 9:25 | 7:22 | >0.999 |
| eGFR (ml/min/1.73 m2) | 66.5 (56.5–78.6) | 74.7 (56.9–83.2) | 0.331 |
| Level of PLIF segment | 0.246 | ||
| L3/L4 | 1 | 2 | |
| L4/L5 | 22 | 15 | |
| L5/S1 | 6 | 5 | |
| L2/L3/L4 | 1 | 0 | |
| L3/L4/L5 | 4 | 3 | |
| L4/L5/S1 | 0 | 4 | |
| T-score | |||
| Lumbar (L2–L4) | −0.5 (−1.6–0.0) | 0.8 (−0.2–2.1) | 0.002 |
| Proximal femur | −1.1 (−1.5–−0.3) | −0.6 (−1.6–0.8) | 0.188 |
| Preoperative HU values of instrumented vertebrae | 127.0 (87.6–167.1) | 135.7 (110.3–184.6) | 0.282 |
Values are expressed as the number of patients or the median (interquartile range).
TCP, titanium-coated poly-ether-ether-ketone; PTA, porous titanium alloy; BMI, body mass index; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; PLIF, posterior lumbar interbody fusion; HU, Hounsfield unit.
Spinal and Spinopelvic Alignment.
| TCP | PTA | P value | |
|---|---|---|---|
| Preoperative PI (°) | 47.4 (41.5–53.3) | 48.0 (39.5–53.6) | 0.923 |
| Preoperative LL (°) | 38.3 (31.2–49.1) | 35.0 (26.2–46.0) | 0.363 |
| Preoperative PT (°) | 20.2 (12.4–25.5) | 21.7 (16.9–26.6) | 0.183 |
| Preoperative PI−LL (°) | 9.3 (−3.6–18.3) | 11.2 (4.5–17.4) | 0.469 |
| Preoperative offset | |||
| PT (°) | −5.1 (−10.6–−1.8) | −3.4 (−7.7–3.9) | 0.067 |
| PI − LL (°) | 0.5 (−12.0–5.8) | 1.5 (−6.3–8.8) | 0.270 |
| Preoperative FA (°) | 15.5 (11.4–20.7) | 16.4 (10.8–21.5) | 0.639 |
| ΔFA (°) | 0.7 (−1.4–3.4) | 1.0 (−1.8–6.7) | 0.558 |
Values are expressed as the median (interquartile range).
HU, Hounsfield unit; TCP, titanium-coated poly-ether-ether-ketone; PTA, porous titanium alloy; PI, pelvic incidence; LL, lumbar lordosis; PT, pelvic tilt; FA, fusion angle; Δ, postoperative value − preoperative value.
Fusion Rate 6 Months and 1 Year Postoperatively.
| 6 months postoperatively | 1 year postoperatively | |
|---|---|---|
| TCP | 66.7% (26/39) | 74.4% (29/39) |
| PTA | 72.2% (26/36) | 83.3% (30/36) |
| P value | 0.626 | 0.406 |
TCP, titanium-coated poly-ether-ether-ketone; PTA, porous titanium alloy.
Figure 1.Distribution of the grades of 6-month postoperative cyst sign in the titanium-coated poly-ether-ether-ketone (TCP) and three-dimensional porous titanium alloy (PTA) cage groups.
Figure 2.Distribution of the grades of 6-month postoperative cage subsidence in the titanium-coated poly-ether-ether-ketone (TCP) and three-dimensional porous titanium alloy (PTA) cage groups.
Figure 3.Distribution of the grades of 1-year postoperative cage subsidence in the titanium-coated poly-ether-ether-ketone (TCP) and three-dimensional porous titanium alloy (PTA) cage groups.
Preoperative Scores of the JOABPEQ.
| TCP | PTA | P value | |
|---|---|---|---|
| Pain-related disorders | 36 (14–71) | 14 (0–36) | 0.031 |
| Lumbar spine dysfunction | 46 (33–75) | 42 (17–67) | 0.383 |
| Gait disturbance | 29 (14–66) | 21 (7–36) | 0.059 |
| Social life function | 45 (24–52) | 30 (9–42) | 0.014 |
| Psychological disorders | 39 (33–50) | 43 (32–56) | 0.730 |
Values are expressed as the median (interquartile range).
JOABPEQ, Japanese Orthopaedic Association Back Pain Evaluation Questionnaire; TCP, titanium-coated poly-ether-ether-ketone; PTA, porous titanium alloy.
Postoperative Effectiveness Rate in Each Category of the JOABPEQ.
| 6 months postoperatively | 1 year postoperatively | |
|---|---|---|
| Pain-related disorders | ||
| TCP | 62.1% | 78.6% |
| PTA | 85.7% | 85.7% |
| P value | 0.070 | 0.729 |
| Lumbar spine dysfunction | ||
| TCP | 48.4% | 64.5% |
| PTA | 55.6% | 55.6% |
| P value | 0.610 | 0.593 |
| Gait disturbance | ||
| TCP | 64.7% | 73.5% |
| PTA | 78.6% | 67.9% |
| P value | 0.272 | 0.780 |
| Social life function | ||
| TCP | 47.1% | 55.9% |
| PTA | 65.5% | 58.6% |
| P value | 0.204 | >0.999 |
| Psychological disorders | ||
| TCP | 38.2% | 44.1% |
| PTA | 37.9% | 20.7% |
| P value | >0.99 | 0.063 |
JOABPEQ, Japanese Orthopaedic Association Back Pain Evaluation Questionnaire; TCP, titanium-coated poly-ether-ether-ketone; PTA, porous titanium alloy.
Figure 4.A typical example of a vertebral endplate cyst formation in the titanium-coated poly-ether-ether-ketone (TCP) cage group (A 75-year-old male patient with L3/L4/L5 posterior lumbar interbody fusion: left, 1 week postoperatively; right, 6 months postoperatively). Diffuse vertebral endplate cysts (arrow heads, cyst sign, grade 2) and a huge cyst with marginal sclerosis (arrows) were observed on the adjacent vertebral endplates on the surface of the TCP cage at L4/L5 (nonunion segment), while no cyst could be found at L3/L4 (union segment).